Gilead Sciences

GILD

GILD
Gilead Sciences Stock Quote
$76.35 $0.29 0.4%
Price as of July 2, 2020, 8:00 p.m. EDT View Interactive GILD Charts

Gilead Sciences created and sells the world’s top-selling HIV medications, Truvada and Atripla, and commands about 75% of the U.S. treatment market and more than 50% worldwide.

Interactive Chart


News & Analysis: Gilead Sciences

The Fool has written over 1700 articles on Gilead Sciences.

All

Market Moves

Podcasts

Earnings